- Ebola outbreak in Western Africa 2014: what is going on with Ebola virus?
-
Na W, Park N, Yeom M, Song D
- KMID: 2049104
- Clin Exp Vaccine Res.
- 2015 Jan;4(1):17-22.
- doi: 10.7774/cevr.2015.4.1.17
The 2014 outbreak of Ebola virus disease (EVD) in West Africa, caused by Ebola virus (Zaire Ebola virus species), is the largest outbreak of EVD in history. It cause hemorrhagic... -
- CITED
-
- Close
- SHARE
-
- Close
- Data Fitting and Scenario Analysis of Vaccination in the 2014 Ebola Outbreak in Liberia
-
Xie Z
- KMID: 2452061
- Osong Public Health Res Perspect.
- 2019 Jun;10(3):187-201.
- doi: 10.24171/j.phrp.2019.10.3.10
OBJECTIVES: This study aimed to extend an epidemiological model (SEIHFR) to analyze epidemic trends, and evaluate intervention efficacy. METHODS: SEIHFR was modified to examine disease transmission dynamics after vaccination for the... -
- CITED
-
- Close
- SHARE
-
- Close
- Purification and characterization of monoclonal IgG antibodies recognizing Ebola virus glycoprotein
-
Han BS, Jang HY, Racine T, Qiu X, Sin JI
- KMID: 2418090
- Clin Exp Vaccine Res.
- 2018 Jul;7(2):119-128.
- doi: 10.7774/cevr.2018.7.2.119
PURPOSE: The goal of this study was to purify and characterize Ebola virus glycoprotein (GP)-specific IgG antibodies from hybridoma clones. MATERIALS AND METHODS: For hybridoma production, mice were injected by intramuscular-electroporation... -
- CITED
-
- Close
- SHARE
-
- Close
- Insights of window-bsed mechanism approach to visualize composite bioData point in feature spaces
-
Daoud M
- KMID: 2447794
- Genomics Inform.
- 2019 Mar;17(1):e4.
- doi: 10.5808/GI.2019.17.1.e4
In this paper, we propose a window-based mechanism visualization approach as an alternative way to measure the seriousness of the difference among data-insights extracted from a composite biodata point. The... -
- CITED
-
- Close
- SHARE
-
- Close
- What do we really fear? The epidemiological characteristics of Ebola and our preparedness
-
Ki M
- KMID: 2380558
- Epidemiol Health.
- 2014;36:e2014014.
- doi: 10.4178/epih/e2014014
Ebola virus disease (hereafter Ebola) has a high fatality rate; currently lacks a treatment or vaccine with proven safety and efficacy, and thus many people fear this infection. As of... -
- CITED
-
- Close
- SHARE
-
- Close
- Knowledge, attitudes, and behavioural risk factors regarding zoonotic infections among bushmeat hunters and traders in Nsukka, southeast Nigeria
-
Ozioko KU, Ikem Okoye C, Nduka Obiezue R, Awudu Agbu R
- KMID: 2438480
- Epidemiol Health.
- 2018;40:e2018025.
- doi: 10.4178/epih.e2018025
OBJECTIVES: In light of the dramatic spread of Ebola virus in some parts of Africa and the 2014 outbreak in Nigeria, a study was conducted to evaluate bushmeat dealers' knowledge... -
- CITED
-
- Close
- SHARE
-
- Close
- Progress of vaccine and drug development for Ebola preparedness
-
Choi WY, Hong KJ, Hong JE, Lee WJ
- KMID: 2049103
- Clin Exp Vaccine Res.
- 2015 Jan;4(1):11-16.
- doi: 10.7774/cevr.2015.4.1.11
Since the first case of Ebola virus disease (EVD) in Guinea was reported in March 2014 by World Health Organization (WHO), the outbreak has continued through the year and the... -
- CITED
-
- Close
- SHARE
-
- Close
- Preferential production of IgM-secreting hybridomas by immunization with DNA vaccines coding for Ebola virus glycoprotein: use of protein boosting for IgG-secreting hybridoma production
-
Lee SH, Han BS, Choe J, Sin JI
- KMID: 2391574
- Clin Exp Vaccine Res.
- 2017 Jul;6(2):135-145.
- doi: 10.7774/cevr.2017.6.2.135
PURPOSE: The goal of this study was to investigate the utility of DNA vaccines encoding Ebola virus glycoprotein (GP) as a vaccine type for the production of GP-specific hybridomas and... -
- CITED
-
- Close
- SHARE
-
- Close
- The 2013-2015 Ebola outbreak in West Africa
-
Kang JH, Chang WY, Choi S, Rho J, Lee KH
- KMID: 2168714
- J Bacteriol Virol.
- 2015 Dec;45(4):304-313.
- doi: 10.4167/jbv.2015.45.4.304
Zaire Ebola virus (EBOV) is a fatal human pathogen, with a high case fatality rate (CFR) averaging up to 78%. In March 2014, the World Health Organization (WHO) was made... -
- CITED
-
- Close
- SHARE
-
- Close
